Costes económicos asociados a la diabetes tipo 1

García, Martínez; Laureano, Florentino Carral San; Fuster, Gabriel Olveira; González, J.A. Girón; Diosdado, Manuel Aguilar

doi:10.1016/s0014-2565(05)72631-x

Cited by 12 publications

(3 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…€2,283), mean age 32.0 (range 5–88) years, mean diabetes duration 8.3 years) [47] and Spain (€2,104, mean age 29.2 (SD 12.2), mean diabetes duration 10.5 (SD 7.9) years) [26].The subjects of the Spanish study had lower costs for hospitalization (€164 vs. €827) [26]. In Germany, a large proportion of diabetes education is commenced in the hospital setting and this is likely to be one reason for high hospitalization costs.…”

Section: Discussionmentioning

confidence: 99%

“…In Germany, a large proportion of diabetes education is commenced in the hospital setting and this is likely to be one reason for high hospitalization costs. Unfortunately, Ballesta et al [26] did not report whether costs for structured patient education were covered by their analysis. Furthermore, Spanish subjects measured blood glucose less frequently than German ones (2.7 vs. 5.1 times per day) and costs for CSII were not included.…”

Section: Discussionmentioning

confidence: 99%

“…HbA1c values were finally categorized according to recommendations of the International Society for Pediatric & Adolescent Diabetes (ISPAD) (<58, 58-<75, ≥75 mmol/mol, corresponding to <7.5, 7.5-<9.0; ≥9%) [25]. All these factors have previously been reported to be associated with costs of care [9], [11], [26]–[28].…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Direct Diabetes-Related Costs in Young Patients with Early-Onset, Long-Lasting Type 1 Diabetes

et al. 2013

View full text Add to dashboard Cite

ObjectiveTo estimate diabetes-related direct health care costs in pediatric patients with early-onset type 1 diabetes of long duration in Germany.Research Design and MethodsData of a population-based cohort of 1,473 subjects with type 1 diabetes onset at 0–4 years of age within the years 1993–1999 were included (mean age 13.9 (SD 2.2) years, mean diabetes duration 10.9 (SD 1.9) years, as of 31.12.2007). Diabetes-related health care services utilized in 2007 were derived from a nationwide prospective documentation system (DPV). Health care utilization was valued in monetary terms based on inpatient and outpatient medical fees and retail prices (perspective of statutory health insurance). Multiple regression models were applied to assess associations between direct diabetes-related health care costs per patient-year and demographic and clinical predictors.ResultsMean direct diabetes-related health care costs per patient-year were €3,745 (inter-quartile range: 1,943–4,881). Costs for glucose self-monitoring were the main cost category (28.5%), followed by costs for continuous subcutaneous insulin infusion (25.0%), diabetes-related hospitalizations (22.1%) and insulin (18.4%). Female gender, pubertal age and poor glycemic control were associated with higher and migration background with lower total costs.ConclusionsMain cost categories in patients with on average 11 years of diabetes duration were costs for glucose self-monitoring, insulin pump therapy, hospitalization and insulin. Optimization of glycemic control in particular in pubertal age through intensified care with improved diabetes education and tailored insulin regimen, can contribute to the reduction of direct diabetes-related costs in this patient group.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%